Lower Tourniquet Pressure Study
A Prospective, Double-blinded, Randomized Controlled Trial Evaluating Effectiveness of Lower Tourniquet Pressures in Hand Surgery
1 other identifier
interventional
93
1 country
3
Brief Summary
This study design is a prospective, double-blinded, randomized controlled trial evaluating the quality of bloodless surgical field with lower tourniquet pressures based on systolic blood pressure (SBP) compared to standard tourniquet pressures. A secondary goal is to evaluate the effect of lower tourniquet pressures on post-operative tourniquet site pain. The rationale behind the study is to provide evidence-based guidelines on tourniquet use to continue providing quality surgical care while minimizing pain and potential harm to patients.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for not_applicable
Started Jul 2022
Typical duration for not_applicable
3 active sites
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
July 19, 2021
CompletedFirst Posted
Study publicly available on registry
August 6, 2021
CompletedStudy Start
First participant enrolled
July 15, 2022
CompletedPrimary Completion
Last participant's last visit for primary outcome
September 27, 2024
CompletedStudy Completion
Last participant's last visit for all outcomes
September 27, 2024
CompletedApril 1, 2025
March 1, 2025
2.2 years
July 19, 2021
March 31, 2025
Conditions
Outcome Measures
Primary Outcomes (1)
Quality of the bloodless surgical field provided by lower tourniquet pressures
Surgeon-completed questionnaire rating the quality of the bloodless operative field using a 4-point Likert scale ranging from 1 (excellent) meaning no blood in the surgical field to 4 (poor) meaning blood in the surgical field obscures view throughout the procedure. This survey will be completed immediately post-operatively.
Immediately After surgery in recovery room time
Secondary Outcomes (1)
Effect of lower tourniquet pressures based on SBP on post-operative tourniquet site pain
Immediately After surgery in recovery room time
Study Arms (2)
Standard Pressure
NO INTERVENTIONThe extremity tourniquet used during hand surgery for these participants will be the standard pressure of 250 mmHg.
Lower Tiered Pressures
EXPERIMENTALThe study intervention is the inflation of the extremity tourniquet to a pressure lower than the standard pressure of 250 mmHg during hand surgery for these participants determined by tiered guidelines based on systolic blood pressure (SBP).
Interventions
The procedural intervention will be inflation of a pneumatic tourniquet to a lower than standard pressure as determined by the patient's SBP in hand and upper extremity surgery. The control will be inflation of a pneumatic tourniquet at a standard pressure of 250 mmHg in hand and upper extremity surgery. The tourniquet used will be the standard tourniquet used for hand and upper extremity surgery at our institutions - a tourniquet 18 inches in length and 3 inches in width manufactured by Stryker (Kalamazoo, MI) used in conjunction with a protective sleeve matched to the size of the tourniquet cuff which is provided by the manufacturer. Both pieces are supplied in a sterile packaging. No other tourniquets will be used.
Eligibility Criteria
You may qualify if:
- Adult patient age 18 or older
- Undergoing hand or upper extremity procedure
- Tourniquet is used for procedure
- Willingness and ability to consent
You may not qualify if:
- Individuals with procedures that are over 120 minutes in length
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (3)
NYU Langone Brooklyn
Brooklyn, New York, 11220, United States
NYU Langone Orthopedic Hospital
New York, New York, 10010, United States
NYU Langone Orthopedic Center
New York, New York, 10016, United States
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Ali Azad
NYU Langone Health
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- DOUBLE
- Who Masked
- PARTICIPANT, INVESTIGATOR
- Purpose
- PREVENTION
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
July 19, 2021
First Posted
August 6, 2021
Study Start
July 15, 2022
Primary Completion
September 27, 2024
Study Completion
September 27, 2024
Last Updated
April 1, 2025
Record last verified: 2025-03
Data Sharing
- IPD Sharing
- Will share
- Shared Documents
- STUDY PROTOCOL, SAP
- Time Frame
- Beginning 9 months and ending 36 months following article publication or as required by a condition of awards and agreements supporting the research.
- Access Criteria
- The investigator who proposed to use the data. Upon reasonable request. Requests should be directed to ali.azad@nyulangone.org. To gain access, data requestors will need to sign a data access agreement.
Individual participant data that underlie the results reported in this article, after deidentification (text, tables, figures, and appendices).